AbbVie
Patents, Design & Utilities

Last updated:

List of all AbbVie patents 265 in total

Status Patent
Application
Utility: TREATMENT OF NON-SMALL CELL LUNG CANCER External link
Filling date: 12 Sep 2025 Issue date: 30 Apr 2020
Grant
Design: Child-resistant medication container assembly External link
Filling date: 12 Sep 2025 Issue date: 28 Apr 2020
Grant
Utility: Bromodomain inhibitors External link
Filling date: 12 Sep 2025 Issue date: 28 Apr 2020
Application
Utility: METHODS OF ADMINISTERING ELAGOLIX External link
Filling date: 12 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 16 Apr 2020
Grant
Utility: Anti-cMet antibody drug conjugates and methods for their use External link
Filling date: 12 Sep 2025 Issue date: 31 Mar 2020
Application
Utility: SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS External link
Filling date: 12 Sep 2025 Issue date: 26 Mar 2020
Grant
Utility: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2- -trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof External link
Filling date: 12 Sep 2025 Issue date: 24 Mar 2020
Grant
Design: Medication packaging combined with dispensing container External link
Filling date: 12 Sep 2025 Issue date: 3 Mar 2020
Application
Utility: 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF External link
Filling date: 12 Sep 2025 Issue date: 27 Feb 2020
Grant
Design: Container cap External link
Filling date: 12 Sep 2025 Issue date: 25 Feb 2020
Application
Utility: Bromodomain Inhibitors External link
Filling date: 12 Sep 2025 Issue date: 13 Feb 2020
Grant
Utility: Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use External link
Filling date: 12 Sep 2025 Issue date: 11 Feb 2020
Grant
Utility: Fused heterocyclic compounds as S1P modulators External link
Filling date: 12 Sep 2025 Issue date: 11 Feb 2020
Application
Utility: PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL External link
Filling date: 12 Sep 2025 Issue date: 6 Feb 2020
Grant
Utility: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof External link
Filling date: 12 Sep 2025 Issue date: 4 Feb 2020
Application
Utility: Elagolix Sodium Compositions and Processes External link
Filling date: 12 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: ENZYMATIC PROCESS FOR THE PREPARATION OF (1S,2R)-2-(DIFLUOROMETHYL)-1-(PROPOXYCARBONYL)CYCLOPROPANECARBOXYLIC ACID External link
Filling date: 12 Sep 2025 Issue date: 23 Jan 2020
Grant
Utility: Methods of administering elagolix External link
Filling date: 12 Sep 2025 Issue date: 21 Jan 2020
Grant
Utility: Anti-A.beta. globulomer 4D10 antibodies External link
Filling date: 12 Sep 2025 Issue date: 21 Jan 2020
Application
Utility: Macrocyclic MCL-1 Inhibitors and Methods of Use External link
Filling date: 12 Sep 2025 Issue date: 9 Jan 2020
Application
Utility: ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 2 Jan 2020
Grant
Utility: Processes for the preparation of (3S,4R)-3,ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof External link
Filling date: 12 Sep 2025 Issue date: 31 Dec 2019
Application
Utility: IL-1 Binding Proteins External link
Filling date: 12 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: TETRACYCLIC BROMODOMAIN INHIBITORS External link
Filling date: 12 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: High Throughput Methods for Screening Chemical Reactions Using Reagent-Coated Bulking Agents External link
Filling date: 12 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: Bromodomain Inhibitors External link
Filling date: 12 Sep 2025 Issue date: 19 Dec 2019
Grant
Utility: Inhibitors of tyrosine kinase 2 mediated signaling External link
Filling date: 12 Sep 2025 Issue date: 17 Dec 2019
Application
Utility: INJECTION DEVICE WITH END OF DOSE INDICATOR External link
Filling date: 12 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: Carbidopa Prodrug External link
Filling date: 12 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: SUBSTITUTED ISOXAZOLOPYRIDAZINONES AND ISOTHIAZOLOPYRIDAZINONES AND METHODS OF USE External link
Filling date: 12 Sep 2025 Issue date: 5 Dec 2019
Application
Utility: ANTI-CD40 ANTIBODIES AND USES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 28 Nov 2019
Application
Utility: Compositions and Methods for Treating HCV Infection External link
Filling date: 12 Sep 2025 Issue date: 28 Nov 2019
Application
Utility: ANTI-EGFR ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: Bromodomain Inhibitors External link
Filling date: 12 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: Methods for Treating HCV External link
Filling date: 12 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: SELECTIVE BCL-2 INHIBITORS IN COMBINATION WITH AN ANTI-PD-1 OR AN ANTI-PD-L1 ANTIBODY FOR THE TREATMENT OF CANCERS External link
Filling date: 12 Sep 2025 Issue date: 7 Nov 2019
Grant
Utility: Process for the preparation of (S)-2-amino-non-8-enoic acid External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2019
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-A]PYRROLO[2,3-E]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE External link
Filling date: 12 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES External link
Filling date: 12 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: Therapeutic DLL4 Binding Proteins External link
Filling date: 12 Sep 2025 Issue date: 17 Oct 2019
Grant
Utility: Synthetic route to anti-viral agents External link
Filling date: 12 Sep 2025 Issue date: 15 Oct 2019
Application
Utility: HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME External link
Filling date: 12 Sep 2025 Issue date: 26 Sep 2019
Application
Utility: Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy External link
Filling date: 12 Sep 2025 Issue date: 26 Sep 2019
Application
Utility: Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy External link
Filling date: 12 Sep 2025 Issue date: 26 Sep 2019
Application
Utility: COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF IRON-RELATED DISORDERS External link
Filling date: 12 Sep 2025 Issue date: 26 Sep 2019

Showing 200 to 250 of 265 patents.